| Sanford Behavioral Health Outpatient Llc | |
|
15146 16th Ave Marne MI 49435-9605 | |
| (844) 776-9651 | |
| Not Available |
| Full Name | Sanford Behavioral Health Outpatient Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 15146 16th Ave, Marne, Michigan |
| Authorized Official Name and Position | Stephanie Robinson (CREDENTIALING & CONTRACTING MANAGER) |
| Authorized Official Contact | 6165209074 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sanford Behavioral Health Outpatient Llc 15146 16th Ave Marne MI 49435-9605 Ph: (844) 776-9651 | Sanford Behavioral Health Outpatient Llc 15146 16th Ave Marne MI 49435-9605 Ph: (844) 776-9651 |
| NPI Number | 1679201271 |
|---|---|
| Provider Enumeration Date | 08/11/2022 |
| Last Update Date | 08/29/2022 |
| Certification Date | 08/29/2022 |
| Medicare PECOS PAC ID | 6709243629 |
|---|---|
| Medicare Enrollment ID | O20230608001937 |
News Archive
Anatomy, Modeling and Biomaterial Fabrication for Dental and Maxillofacial Applications provides readers with information about dental implants and biomaterial fabrication for maxillofacial procedures and dental bone / tissue repair.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.
A University of Maryland-led team of international experts will investigate ways to understand, prevent and reverse the radicalization of young people in destabilized areas of the world, and to keep them from embracing terror as a political tool.
Huma Q. Rana, MD of Harvard Medical School's Dana Farber Cancer Institute is the recipient of the 2014 Richard King Trainee Award. This award was instituted five years ago by the ACMG Foundation for Genetic and Genomic Medicine to encourage ABMG or genetic counseling trainees in their careers and to foster the publication of the highest quality research in ACMG's peer-reviewed journal, Genetics in Medicine (GIM).
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679201271 | NPI | - | NPPES |
| Provider Name | Gilbert A Masterson |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1497740930 PECOS PAC ID: 3375635006 Enrollment ID: I20070824000761 |
News Archive
Anatomy, Modeling and Biomaterial Fabrication for Dental and Maxillofacial Applications provides readers with information about dental implants and biomaterial fabrication for maxillofacial procedures and dental bone / tissue repair.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.
A University of Maryland-led team of international experts will investigate ways to understand, prevent and reverse the radicalization of young people in destabilized areas of the world, and to keep them from embracing terror as a political tool.
Huma Q. Rana, MD of Harvard Medical School's Dana Farber Cancer Institute is the recipient of the 2014 Richard King Trainee Award. This award was instituted five years ago by the ACMG Foundation for Genetic and Genomic Medicine to encourage ABMG or genetic counseling trainees in their careers and to foster the publication of the highest quality research in ACMG's peer-reviewed journal, Genetics in Medicine (GIM).
› Verified 6 days ago
News Archive
Anatomy, Modeling and Biomaterial Fabrication for Dental and Maxillofacial Applications provides readers with information about dental implants and biomaterial fabrication for maxillofacial procedures and dental bone / tissue repair.
Ligon Discovery announced today that it has entered into a collaboration agreement with Lycera Corporation to apply its Small Molecule Microarray (SMM) screening technology to identify first-in-class drug candidates for immune disorders. Ligon will apply its SMM technology to screen protein targets identified by Lycera as critical to the development of certain immune disorders. Financial terms were not disclosed.
Actavis plc today announced that it has received approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application for Telmisartan Immediate-Release Tablets, 20 mg, 40 mg and 80 mg, a generic equivalent to Boehringer Ingelheim's Micardis. Actavis intends to launch the product immediately.
A University of Maryland-led team of international experts will investigate ways to understand, prevent and reverse the radicalization of young people in destabilized areas of the world, and to keep them from embracing terror as a political tool.
Huma Q. Rana, MD of Harvard Medical School's Dana Farber Cancer Institute is the recipient of the 2014 Richard King Trainee Award. This award was instituted five years ago by the ACMG Foundation for Genetic and Genomic Medicine to encourage ABMG or genetic counseling trainees in their careers and to foster the publication of the highest quality research in ACMG's peer-reviewed journal, Genetics in Medicine (GIM).
› Verified 6 days ago
Mi Rehab Solutions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 14455 Tisch Ct, Marne, MI 49435 Phone: 616-723-6805 | |
Shining Shield Medical Group, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15140 16th Ave, Marne, MI 49435 Phone: 269-704-7563 | |
Sanford Comprehensive Treatment Eating Disorders Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15146 16th Ave, Marne, MI 49435 Phone: 844-776-9651 |